 
                
          
Founded in 2007, Clinica Group has an experience in interventional, observational and pharmaco-epidemiological management studies, in different therapeutic areas, which helped them meet their customers’ various needs and place their satisfaction at the center of their business.
Their employees work in accordance with international standards (Declaration of Helsinki, ICH-GCP etc.) in order to meet their pharmaceutical and institutional partners’ expectations.
Their main goals are the quality of their activity, the satisfaction of their customers, and the adherence to ethical values.
Learn more: www.clinicagroup.com
A LEADING POSITION AND 
AN INTERNATIONAL DEPLOYMENT
64 +
                        countries 
involved
                    
20 000 +
                        investigational 
Centres
                    
3 million +
                        patients 
in database
                    
50 000 +
                        users 
worlwide
                    
 
        October 30, 2025
February 1–3, 2025 – Amsterdam | Booth 16-17-18 We’re excited to announce our participation to EUCROF26! Visit our booth to explore CleanWeb™, our advanced eClinical suite for managing clinical trials, registries, and early access programs. Together with our CRO Alliance partners (BlueCompanion, Clinica Group, DeltaClinical, NextCRO, Phoenix CR), we offer tailored solutions to support your […]
October 30, 2025
Applied Clinical Trials Online Clinical trials have traditionally relied on paper-based consent forms to secure the participant’s approval. While this approach is still common in many studies, it presents practical challenges. Participants may struggle with dense medical jargon, documents can be misplaced, and re-consenting often adds to site workload. As decentralized and hybrid trial models […]
October 30, 2025
Biopharm International To improve patient outcomes, experience, and engagement, patient-centric drug development is essential. By focusing on patients’ needs, experiences, and preferences, drug developers can create treatments that are optimally effective and tolerated. This leads to improved adherence to treatment regimens and better overall health outcomes when compared with not taking these factors into consideration […]